Mendus: ALISON Correlates Disease Control with Immune Response - Redeye

Redeye comments on the data from ALISON, a study of 17 patients in ovarian cancer treated with vididencel, presented at ASCO. The main result is that patients responding to the vaccine had an improved disease control.

Länk till analysen i sin helhet: https://www.redeye.se/research/1170827/mendus-alison-correlates-disease-control-with-immune-response?utm_source=finwire&utm_medium=RSS